BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34270823)

  • 1. miR-181c regulates MCL1 and cell survival in GATA2 deficient cells.
    Wang W; Chen R; Droll S; Barber E; Saleh L; Corrigan-Cummins M; Trick M; Anastas V; Hawk NV; Zhao Z; Vinh DC; Hsu A; Hickstein DD; Holland SM; Calvo KR
    J Leukoc Biol; 2022 Apr; 111(4):805-816. PubMed ID: 34270823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-153-3p regulates progression of ovarian carcinoma in vitro and in vivo by targeting MCL1 gene.
    Li C; Zhang Y; Zhao W; Cui S; Song Y
    J Cell Biochem; 2019 Nov; 120(11):19147-19158. PubMed ID: 31297886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2-p53 mediate a miR-181c-3p/LIF axis to regulate low dose-rate radiation-induced DNA damage in human B lymphocytes.
    Chen Y; Gong Y; Qin H; Wei S; Wei Y; Yu Y; Lin X; Shuai P; Wang T; Guo C; Wang Q; Li G; Meng L; Yi L
    Ecotoxicol Environ Saf; 2024 Jan; 270():115848. PubMed ID: 38134636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
    Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
    Robbins DJ; Pavletich TS; Patil AT; Pahopos D; Lasarev M; Polaki US; Gahvari ZJ; Bresnick EH; Matson DR
    Blood Adv; 2024 Jan; 8(1):80-92. PubMed ID: 38029365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukemia mutations corrupt but do not abrogate GATA-2 function.
    Katsumura KR; Mehta C; Hewitt KJ; Soukup AA; Fraga de Andrade I; Ranheim EA; Johnson KD; Bresnick EH
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10109-E10118. PubMed ID: 30301799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia.
    Shen C; Chen MT; Zhang XH; Yin XL; Ning HM; Su R; Lin HS; Song L; Wang F; Ma YN; Zhao HL; Yu J; Zhang JW
    PLoS Genet; 2016 Sep; 12(9):e1006259. PubMed ID: 27617961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
    Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
    Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
    Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
    Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency.
    Castaño J; Romero-Moya D; Richaud-Patin Y; Giorgetti A
    Stem Cell Res; 2021 Aug; 55():102445. PubMed ID: 34284273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose-Derived Stem Cells-Derived Exosomes with High Amounts of Circ_0001747 Alleviate Hypoxia/Reoxygenation-Induced Injury in Myocardial Cells by Targeting MiR-199b-3p/MCL1 Axis.
    Zhou D; Dai Z; Ren M; Yang M
    Int Heart J; 2022; 63(2):356-366. PubMed ID: 35354755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency.
    Wu Z; Gao S; Diamond C; Kajigaya S; Chen J; Shi R; Palmer C; Hsu AP; Calvo KR; Hickstein DD; Holland SM; Young NS
    Blood Adv; 2020 Jun; 4(12):2656-2670. PubMed ID: 32556286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTBP1 enhances miR-101-guided AGO2 targeting to MCL1 and promotes miR-101-induced apoptosis.
    Cui J; Placzek WJ
    Cell Death Dis; 2018 May; 9(5):552. PubMed ID: 29748555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency.
    Koegel AK; Hofmann I; Moffitt K; Degar B; Duncan C; Tubman VN
    Pediatr Blood Cancer; 2016 Oct; 63(10):1844-7. PubMed ID: 27232273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells-derived extracellular vesicles containing miR-378a-3p inhibit the occurrence of inflammatory bowel disease by targeting GATA2.
    Li P; Zhang HY; Gao JZ; Du WQ; Tang D; Wang W; Wang LH
    J Cell Mol Med; 2022 Jun; 26(11):3133-3146. PubMed ID: 35582765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-induced, TNFR-dependent miR-181c downregulation promotes MLL1 and NF-κB target gene expression in human microglia.
    Yin M; Chen Z; Ouyang Y; Zhang H; Wan Z; Wang H; Wu W; Yin X
    J Neuroinflammation; 2017 Jun; 14(1):132. PubMed ID: 28662718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
    Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
    Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
    Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
    Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.